MariMed Inc 最大收入来源是 Cannabis and Cannabis-infused - Retail,在最近的收益报告中收入为 89,024,000。就地区而言, United States 是 MariMed Inc 的主要市场,收入为 159,826,000。
MariMed Inc 是否盈利?
否,根據最新的財務報表,MariMed Inc 的淨亏损為 $0
MariMed Inc 有負債嗎?
否,MariMed Inc 的負債為 0
MariMed Inc 的流通股有多少?
MariMed Inc 的總流通股為 0
关键数据
前收盘价
$0.0695
开盘价
$0.0695
当日区间
$0.067 - $0.0737
52周范围
$0.064 - $0.23
交易量
76.0K
平均成交量
636.2K
股息收益率
--
每股收益(TTM)
-0.03
市值
$28.1M
什么是 MRMD?
MariMed, Inc. engages in the cultivation, processing, and sale of branded cannabis products. The company is headquartered in Norwood, Massachusetts and currently employs 808 full-time employees. The company went IPO on 2012-05-04. The firm develops, owns, and manages seed to sale of state-licensed cannabis facilities for the cultivation, production, and dispensing of medicinal and adult-use cannabis. The company develops its own brands of premium cannabis flower, concentrates, edibles, and other precision-dosed products utilizing its proprietary strains and formulations. The company also licenses its proprietary brands, along with other cannabis products, in domestic markets. Its products are developed in various consumption formats, including whole flower, pre-rolled flower, vape cartridges, concentrates, and edibles. The Company’s brands include Nature’s Heritage, a premium brand of cannabis flower, vapes, and concentrates; Betty’s Eddies, cannabis fruit chews that deliver better sleep, pain relief, stress relief, and more. The Betty's Eddies line also includes a cannabis-infused ice cream created in partnership with ice cream brand Emack & Bolio's.